Coastal Compounding Pharmacy: Same Name, Different Cities in 2026

Introduction: Why “Coastal Compounding Pharmacy” Leads to So Many Different Doors

Anyone who types “coastal compounding pharmacy” into a search engine quickly discovers that there is no single answer. The results surface several independent businesses, each with a similar name, operating in different states and serving different communities. None belongs to a single national brand. The confusion is understandable, and it is the reason this guide exists.

This article serves two purposes. First, it offers a quick navigational guide to help readers identify which local “Coastal” pharmacy they may actually be looking for. Second, it provides a framework for evaluating the quality and safety standards of any compounding pharmacy.

At least five independently owned pharmacies use “Coastal” or similar names across Savannah, Georgia; Riviera Beach, Florida; Portland, Maine; and Wilmington, North Carolina. None is affiliated with another. Once a reader knows which pharmacy they were searching for, or discovers that none of them serve their state, a more important question remains: how should pharmacy quality be judged? The answer lies in objective standards such as PCAB accreditation, USP <800> compliance, and independent third-party testing. These standards apply regardless of a pharmacy’s name or its proximity to a coastline.

The “Coastal” Name Problem: At Least Five Unrelated Pharmacies, Four States

The overlap is not a coincidence so much as a naming trend. “Coastal” is a popular, generic descriptor for businesses in seaside markets and lifestyle-focused communities. Multiple independent owners have arrived at nearly identical names with no corporate relationship between them.

That distinction matters. These are entirely separate legal businesses, not franchises, chains, or branch locations of a parent company. As a result, their credentials, formulary capabilities, staffing, and accreditation status differ from one pharmacy to the next. A good experience at one “Coastal” pharmacy says nothing about the others.

The breakdown below functions as a quick-reference tool for readers trying to locate a specific business.

Coastal Compounding Pharmacy: Savannah, Georgia (Two Distinct Entities)

Savannah stands out because it appears to have two separate businesses using the “Coastal Compounding Pharmacy” name.

• Entity one was established in 2010 and describes itself as growing steadily to meet the needs of customers in the historic city. Its staff includes 15 people, five of whom are pharmacists.
• Entity two states that it has served the Savannah community since 1998, with three pharmacists holding 30 years of combined experience.

Readers searching for a Savannah-based compounding pharmacy should verify the exact street address and phone number before booking a consultation or transferring a prescription. Online directories may conflate the two businesses, mixing reviews, hours, or contact details.

Coastal Compounding: Riviera Beach, Florida

Coastal Compounding in Riviera Beach is a separate Florida business that specializes in customized medications made to physicians’ orders, based in what its website calls “sunny Riviera Beach, Florida.” Its geographic focus is the South Florida and West Palm Beach area. It has no corporate connection to the Georgia, Maine, or North Carolina businesses.

Coastal Pharmacy & Wellness: Portland, Maine

Coastal Pharmacy & Wellness positions itself as a leading compounding pharmacy and nutritional supplement provider in the Portland, Maine area, offering customized medications alongside broader wellness solutions. That supplement and wellness emphasis sets it apart from the other “Coastal” businesses, which focus more narrowly on prescription compounding.

Coastal Pharmacy & Compounding: Wilmington, North Carolina

Coastal Pharmacy & Compounding has served the Wilmington community since April 1991, making it the longest-tenured of the “Coastal”-named businesses identified here. It also offers pet compounding and weight-loss products, which may appeal to readers with broader household pharmacy needs.

Like the others, this pharmacy is independently owned and is not affiliated with the Savannah, Riviera Beach, or Portland businesses.

What This Fragmentation Reveals, and the Question It Doesn’t Answer

Because none of these “Coastal” businesses are chains, choosing among them is largely a matter of geography and personal preference. The shared name does not signal shared quality standards.

The larger gap is educational. Local directory listings and small business pages for these pharmacies tend to focus on hours, basic service lists, and local character. Descriptions of pharmacists “trained in the art and science of making each prescription work,” or lists of dosage forms such as lollipops, suppositories, and nasal sprays, tell patients what a pharmacy makes. They rarely explain how a patient should evaluate safety, accreditation, or regulatory compliance.

Some details are easy to miss. At least one coastal-named pharmacy explicitly discloses that it is not a sterile compounding facility. That is an honest and useful disclosure, but many patients would not recognize its significance unless they already understood the difference between sterile and non-sterile compounding.

Whether a reader ultimately chooses a local “Coastal” pharmacy or a nationwide provider, the same quality checklist should apply. That checklist is exactly what most of these websites leave unexplained.

How to Evaluate Any Compounding Pharmacy in 2026 (Coastal or Not)

The following framework is vendor-neutral. Readers can apply it to any compounding pharmacy, whether it operates down the street or ships across the country.

This diligence matters more each year. The U.S. compounding pharmacy market is projected to grow from $7.42 billion in 2026 to $12.79 billion by 2035, a 6.24% compound annual growth rate. The 503A segment alone, which covers most personalized and hormone-related compounding, is expected to grow from $5.03 billion to $8.58 billion over the same period. More patients than ever will be choosing a compounding pharmacy, and they need to know what “good” looks like.

Check for PCAB Accreditation

The Pharmacy Compounding Accreditation Board (PCAB) provides voluntary, rigorous third-party review of a pharmacy’s quality systems, facilities, and processes. Accreditation is not legally required, which is precisely why it is meaningful: a PCAB-accredited pharmacy has chosen to meet a higher bar than the minimum.

Patients should ask directly about PCAB status or look for it on a pharmacy’s website or licensing page. Nationwide Compounding Rx® offers an example of how this credential looks when properly disclosed. The pharmacy states its PCAB accreditation prominently, describing it as a major accomplishment that reflects a full commitment to the highest quality and safety standards.

Confirm USP <795>, <797>, and <800> Compliance

The United States Pharmacopeia (USP) publishes the core standards governing compounding:

• USP <795> covers non-sterile compounding, such as capsules, creams, and oral liquids.
• USP <797> covers sterile compounding, such as injectables.
• USP <800> covers the safe handling of hazardous drugs.

Every 503A pharmacy must comply with all three chapters, which became officially enforceable on November 1, 2023. However, state enforcement timelines vary. Kentucky’s Board of Pharmacy, for example, did not begin enforcing the 2022 revisions until January 1, 2026. Patients should not assume enforcement is uniform everywhere. Nationwide Compounding Rx® tracks these differences in its state regulations map for compounding pharmacies.

USP <800> deserves particular attention. Compliance with this chapter is designed to eliminate cross-contamination risk when hazardous medications are handled, protecting both patients and pharmacy staff.

Readers should ask any pharmacy, coastal-named or otherwise, which USP chapters it complies with and whether that compliance has been independently verified.

Understand 503A vs. 503B Status

In 2026, 503A pharmacies make up roughly 65% of the U.S. compounding market by pharmacy type. Most “Coastal”-named independents fall into this category, as does Nationwide Compounding Rx®. These pharmacies compound medications based on a valid, patient-specific prescription.

The arrangement involves a trade-off. Qualifying 503A preparations are exempt from FDA pre-market approval, current Good Manufacturing Practice (cGMP) requirements, and standard labeling rules. In exchange, compounding must be tied to a prescription for an identified individual patient. State boards of pharmacy serve as the primary oversight bodies.

This matters because 503A oversight is state-based. License status, inspection history, and enforcement rigor can vary meaningfully by state and by individual pharmacy. Patients can usually verify a pharmacy’s license through their state board of pharmacy.

Ask About Independent Third-Party Testing

Third-party testing adds a layer of verification beyond a pharmacy’s internal quality control. Independent labs can confirm the potency, sterility, and purity of compounded preparations.

Two practical questions help separate pharmacies:

1. Are active ingredients sourced from FDA-inspected and cleared vendors?
2. Do finished preparations undergo independent testing before dispensing?

Local directory-style listings rarely address either question. That makes testing an easy but important topic to raise directly with any pharmacy under consideration.

Evaluate Experience, Turnaround Time, and Shipping Transparency

Experience varies widely, even among accredited pharmacies. According to the APC 2025–2026 Snapshot, the average compounding pharmacist has about 19 years of experience. That figure is a useful benchmark when comparing pharmacy teams.

Turnaround time is another practical consideration. A 1 to 2 business day turnaround is a reasonable industry benchmark. Patients should also ask whether same-day pickup or expedited shipping is available.

For nationwide providers, shipping transparency is essential. Reputable pharmacies clearly disclose which states they serve and which they do not, rather than leaving patients to discover limitations after submitting a prescription.

Where Nationwide Compounding Rx® Fits: A Quality Benchmark, Not a Geographic Competitor

Nationwide Compounding Rx® is not trying to be “the coastal pharmacy near you.” It is a PCAB-accredited, USP <800>-compliant 503A pharmacy that applies the standards described above regardless of which coast or state a patient calls home.

Key specifics include:

• Location: Scottsdale, Arizona (14000 N. Hayden Rd., Suite 104).
• Experience: More than 40 years of combined team experience across bioidentical hormone replacement therapy (BHRT), pain management, dermatology, and pediatrics, along with GLP-1/peptide support and sports medicine formulations.
• Sourcing and testing: High-grade chemicals sourced from FDA-inspected and cleared vendors, with independent third-party testing.
• Formulation range: Sterile and non-sterile preparations, including capsules, liquids, topicals, troches, tablets, suppositories, and kid-friendly flavored forms, with options free of dyes, fillers, preservatives, and allergens.
• Turnaround: 1 to 2 business days, with same-day pickup available for some medications locally in Scottsdale.

The pharmacy ships nationwide, with service levels that vary by state. States generally fall into one of three tiers: fully licensed for both sterile and non-sterile compounding, licensed for non-sterile compounding only (with sterile licensing pending), or not yet licensed for sterile and/or non-sterile compounding. This tiered approach is directly relevant to readers in Wilmington, North Carolina, or any other location searching for “coastal” compounding: patients and prescribers should check Nationwide Compounding Rx®’s current state licensing status for their specific location rather than assuming availability either way. Nationwide Compounding Rx® states these distinctions plainly rather than obscuring them.

That transparency is the point of this section. Many local “Coastal” pharmacies rely primarily on community reputation. Nationwide Compounding Rx® illustrates what it looks like when a compounding pharmacy proactively documents its accreditation, compliance, sourcing, and service area so patients and prescribers can evaluate it on the record.

A Quick-Reference Checklist Before Choosing Any Compounding Pharmacy

Before transferring a prescription or booking a consultation, patients and providers can work through the following questions:

• PCAB accreditation: Is the pharmacy accredited, and is that status publicly disclosed?
• USP compliance: Does it comply with USP <795>, <797>, and <800>? Has compliance been independently verified?
• 503A or 503B classification: Which category does it fall under, and which state boards oversee it?
• Sterile capability: Does it compound sterile preparations, or only non-sterile ones?
• Third-party testing: Are finished preparations independently tested for potency, sterility, and purity?
• Sourcing standards: Are ingredients purchased from FDA-inspected and cleared vendors?
• Staff experience: How does the team’s experience compare with the 19-year national average?
• Turnaround time: Can it meet a 1 to 2 business day benchmark? Is same-day pickup available?
• Licensing and shipping transparency: Which states does it serve, and which does it not?

This checklist works equally well when contacting one of the “Coastal” pharmacies in Savannah, Riviera Beach, Portland, or Wilmington, and when evaluating any other compounding option, local or national.

Conclusion: Find the Right “Coastal” Pharmacy, Then Judge It by the Right Standards

Readers now have a clear map of the distinct “Coastal” pharmacies: two separate entities in Savannah, one in Riviera Beach, one in Portland, and one in Wilmington. Each is independently owned, and none shares credentials with the others.

More importantly, readers have a durable framework for judging pharmacy quality beyond name recognition. Geography and branding should not be the deciding factors in choosing a compounding pharmacy. Accreditation, USP compliance, sourcing practices, and independent testing should be.

That framework will remain useful well beyond 2026. As the U.S. compounding market grows toward a projected $12.79 billion by 2035, the number of pharmacy options will expand, and the ability to ask the right questions will matter even more.

Ready to Work with a PCAB-Accredited, Nationwide Compounding Partner?

Patients and healthcare providers who did not find what they needed locally, or who want a quality-vetted alternative, can explore Nationwide Compounding Rx®’s services at nationwidecompounding.com.

Physicians, clinics, and healthcare organizations evaluating a new compounding partner can begin with the pharmacy’s provider partnership framework: Connect, Collaborate, Create, Care. The process is designed to work alongside prescribers and care teams rather than function as a transactional dispensary.

Contact Nationwide Compounding Rx®:

• Phone: (480) 499-8379
• Fax: 480-699-5341
• Hours: Monday through Friday, 7:00 AM to 3:30 PM
• Address: 14000 N. Hayden Rd., Suite 104, Scottsdale, AZ 85260
• Online: Website contact forms (with responses within one business day), plus secure Provider and Patient Portals for prescription submission, order tracking, refill requests, and account management.